GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Nouveau Life Pharmaceuticals Inc (OTCPK:NOUV) » Definitions » Deferred Tax

Nouveau Life Pharmaceuticals (Nouveau Life Pharmaceuticals) Deferred Tax : $0.00 Mil (TTM As of Mar. 2008)


View and export this data going back to . Start your Free Trial

What is Nouveau Life Pharmaceuticals Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Nouveau Life Pharmaceuticals's change in deferred tax for the three months ended in Mar. 2008 was $0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2008 was $0.00 Mil.

Nouveau Life Pharmaceuticals Deferred Tax Historical Data

The historical data trend for Nouveau Life Pharmaceuticals's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nouveau Life Pharmaceuticals Deferred Tax Chart

Nouveau Life Pharmaceuticals Annual Data
Trend Jun03 Jun04 Jun05 Jun06
Deferred Tax
- - - -

Nouveau Life Pharmaceuticals Quarterly Data
Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nouveau Life Pharmaceuticals Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nouveau Life Pharmaceuticals Deferred Tax Related Terms

Thank you for viewing the detailed overview of Nouveau Life Pharmaceuticals's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Nouveau Life Pharmaceuticals (Nouveau Life Pharmaceuticals) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Nouveau Life Pharmaceuticals Inc (OTCPK:NOUV) » Definitions » Deferred Tax
Comparable Companies
ENZB INBP BSPM ATHJF CPHI INNV ALQA NVGN AXN CHEXD IMNP TNXP PRPH OASM PXSLY NNVC ALIM CKDXF NBRV ZGNX
Traded in Other Exchanges
N/A
Address
370 Amapola Avenue, Suite 200-A, Torrance, CA, USA, 90501
Website
https://www.nouv.ai
Nouveau Life Pharmaceuticals Inc is a healthcare solution company that provides non-face-to-face care services. Its product portfolio includes SILBY, Tomy, Amy, Maro, and Kiromy.